A new study from UCLA Health suggests that compressing six weeks of transcranial magnetic stimulation into a single intensive five-day protocol may offer comparable symptom relief for many patients ...

Researchers propose "exercise mimetics" (exercise pills) to treat depression by hacking the muscle-brain axis for those unable to physically exercise.

Young women with depression are more likely to have lower levels of taurine in their hippocampus than healthy controls. The corresponding study was published in Biological Psychiatry. Between 2013 and ...

On Tuesday, Alto Neuroscience, Inc. (NASDAQ:ANRO) announced an asset purchase agreement with Chase Therapeutics Corporation for a portfolio of dopamine agonist drug combinations for ...

FDA grants Breakthrough Therapy designation to luvesilocin for postpartum depression following positive results from the phase 2 RECONNECT trial.

Flow Neuroscience, a small Swedish company treating depression with brain-stimulating headsets, released early data on Monday showing that its device relieved depressive symptoms in clinical trials.

Neuropsychiatric drug development is rife with clinical trial failures, but Alto Neuroscience aims to overcome these hurdles with a precision medicine approach that matches a patient to a drug. A ...

People living with depression cannot just get over it. They need support, healing, and to discover the epicenter of their ...

A new study found that depression may increase the risk of menstrual pain through factors like sleep disturbances. The findings suggest that treating sleep and mental health issues may help relieve ...

Johnson & Johnson, already a big player in neuroscience drugs, is adding to its portfolio and pipeline with a deal to acquire Intra-Cellular Therapies, a company whose main asset has the potential to ...